Clinical Trial Update: Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing asenapine with olanzapine for efficacy and safety in patients with schizophrenia, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Asenapine (asenapine)
• olanzapine (olanzapine)

Snippet

Sponsor: Organon and Co | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED